Effect of biodegradable polyrotaxanes on platelet activation

Bioconjugate Chemistry

Volumn 9, Issue 1, 1998, Pages 118-125

  Yui, Nobuhiko ^a   Ooya, Tooru ^a   Kumeno, Takashi ^a  

^a JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOMATERIALS; METABOLISM; PLATELETS; POLYETHYLENE GLYCOLS;

CELLULAR RESPONSE; INTRACELLULAR METABOLISM; MEMBRANE FLUIDITY; PEPTIDE LINKAGES; PHYSICO-CHEMICAL INTERACTIONS; PLATELET ACTIVATION; POLYROTAXANES; RED BLOOD CELL; SYNTHESISED; Α-CYCLODEXTRINS;

CELL MEMBRANES;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0031961864     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970189c     Document Type: Article

References (29)

1. Behr, J.-P. (1994) The Lock-and-Key Principle, John Wiley & Sons, Chichester, U.K.
2. Lehn, J.-M. (1995) Supramolecular Chemistry, VCH, Weinheim, Germany.
3. Harada, A., and Kamachi, M. (1990) Complex formation between poly(ethylene glycol) and α-cyclodextrin. Macromolecules 23, 2821-2823.
4. Harada, A., Li, J., and Kamachi, M. (1992) The molecular necklace: a rotaxane containing many threaded α-cyclodextrins. Nature 356, 325-327.
5. Ooya, T., Mori, H., Terano, M., and Yui, N. (1995) Synthesis of a biodegradable polymeric supramolecular assembly for drug delivery. Macromol. Rapid Commun. 16, 259-263.
6. Yui, N., and Ooya, T. (1996) Novel design of supramolecular-structured biodegradable polymer for drug delivery. In Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems (N. Ogata, S. W. Kim, J. Feijen, and T. Okano, Eds.) pp 333-334, Springer, Tokyo.
7. Ooya, T., and Yui, N. (1997) Synthesis and characterization of biodegradable polyrotaxanes as a novel supramolecular-structured drug carrier. J. Biomater. Sci., Polym. Ed. 8, 437-455.
8. Rîhová, B. (1996) Biocompatibility of biomaterials: hemocompatibility, immunocompatibility and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers. Adv. Drug Deliv. Rev. 21, 157-176.
9. Kamimura, W., Ooya, T., and Yui, N. (1997) Interaction of supramolecular assembly with hairless rat stratum corneum. J. Controlled Release 44, 295-299.
10. Ooya, T., Sugawara, H., and Yui, N. (1997) Interaction of supramolecular-structured polyrotaxanes with hairless rat stratum corneum and its effect on indomethacin permeation. Drug Delivery Syst. 12, 89-94.
11. Yui, N., Suzuki, K., Okano, T., Sakurai, Y., Ishikawa, C., Fujimoto, K., and Kawaguchi, H. (1993) Mechanism of cytoplasmic calcium changes in platelets in contact with polystyrene and poly(acrylamide-co-methacrylic acid) surfaces. J. Biomater. Sci., Polym. Ed. 4, 199-215.
12. Yui, N., Suzuki, K., Okano, T., Sakurai, Y., Nakano, M., Ishikawa, C., Fujimoto, K., and Kawaguchi, H. (1995) Cytoplasmic calcium level and membrane fluidity of platelets contacting poly(acrylamide-co-methacrylic acid) particles with different surface properties. J. Biomater. Sci., Polym. Ed. 7, 253-264.
13. 1, Forskolin). Biochem. Biophys. Res. Commun. 113, 598-604.
14. Yui, N., Kataoka, K., Sakurai, Y., Aoki, T., Sanui, K., and Ogata, N. (1988) In vitro and in vivo studies on antithrombogenicity of poly(propylene oxide) segmented nylon 610 in relation to its crystalline-amorphous microstructure. Biomaterials 9, 225-229.
15. Takei, Y. G., Yui, N., Okano, T., Haruyama, A., Sanui, K., Sakurai, Y., and Ogata, N. (1994) Postadsorptive behavior of plasma proteins on poly(propylene oxide)-segmented nylon-610 surfaces and its implication in preventing contact-induced activation of platelets on these surfaces. J. Biomater. Sci., Polym. Ed. 6, 149-167.
16. Yui, N. (1996) Nonthrombogenic polymers (Multiblock copolymers of polyether and polyamide). In Polymeric Materials Encyclopedia (J. C. Salamone, Ed.) Vol. 6, pp 4618-4624, CRC Press, New York.
17. Anderson, D. W., Zimmerman, J. E., and Callahan, F. M. (1964) The use of esters of N-hydroxysuccinimide in peptide synthesis. J. Am. Chem. Soc. 86, 1839-1842.
18. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
19. Dodge, J. T., Mitchell, C., and Hanahan, D. J. (1963) The preparation and characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100, 119-130.
20. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurement of protein using bicichoninic acid, Anal. Biochem. 150, 76-85.
21. Stoltz, J. F., and Donner, M. (1985) Fluorescence polarization applied to cellular microrheology. Biorheolgy 22, 227-247.
22. Sumbilla, C., and Lakowicz, J. R. (1982) Fluorescence studies of red blood cell membranes from individuals with Huntington's disease. J. Neurochem. 38, 1699-1707.
23. Beretz, A., Stirle, A., Anton, R., and Cazenave, J-P. (1981) Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. Biochem. Pharmacol. 31, 3597-3600.
24. Gilman, A. G. (1970) A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc. Natl. Acad. Sci. U.S.A. 67, 305-312.
25. Ooya, T., and Yui, N. (1997) Regulation of intracellular metabolism by biodegradable polyrotaxanes. J. Biomater. Sci. Polym. Ed. (in press).
26. Wilson, D. F., and Chance, B. (1966) Reversal of azide inhibition by uncouplers. Biochem. Biophys. Res. Commun. 23, 751-756.
27. Ooya, T., and Yui, N. (1997) Degradation kinetics and supramolecular association of biodegradable polyrotaxanes. Proc. Int. Symp. Controlled Release Bioact. Mater., 24th, 461-462.
28. Feinstein, M. B., Zavoico, G. B., and Halenda, S. P. (1985) Calcium and cyclic AMP: Antagonistic modulators of platelet function. In The platelets: Physiology and Pharmacology (G. L. Longenecker, Ed.) pp 237-269, Academic, London.
29. Hirata, F., Strittmatter, W. J., and Axelrod, J. (1979) β-Adrenergic receptor agonists increase phospholipid methylation, membrane fluidity, and β-Adrenergic receptor-adenylate cyclase coupling. Proc. Natl. Acad. Sci. U.S.A. 76, 368-372.